Male circumcision in Siaya and Bondo Districts, Kenya: Prospective cohort study to assess behavioral disinhibition following circumcision

Journal of Acquired Immune Deficiency Syndromes

Volumn 44, Issue 1, 2007, Pages 66-70

  Agot, Kawango E ^a,e   Kiarie, James N ^b   Nguyen, Huong Q ^c   Odhiambo, Jacob O ^a   Onyango, Tom M ^d   Weiss, Noel S ^c  

^a IMPACT RESEARCH AND DEVELOPMENT ORGANIZATION   (Kenya)

^b UNIVERSITY OF NAIROBI   (Kenya)

^c UNIVERSITY OF WASHINGTON   (United States)

^d MINISTRY OF HEALTH   (Kenya)

^e Impact R and D Organization/UNIM Project   (Kenya)

Author keywords

Behavioral disinhibition; HIV prevention; HIV AIDS; Kenya; Male circumcision

Indexed keywords

ADULT; ARTICLE; CIRCUMCISION; CONDOM; CONTROLLED STUDY; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEXUAL BEHAVIOR; SINGLE MAN;

ADULT; CIRCUMCISION, MALE; COHORT STUDIES; HIV INFECTIONS; HUMANS; KENYA; MALE; MARITAL STATUS; PROSPECTIVE STUDIES; SEXUAL BEHAVIOR;

EID: 33845997802     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.qai.0000242455.05274.20     Document Type: Article

References (15)

1. Weiss HA, Quigley MA, Hayes RJ. Male circumcision and risk of HIV infection in sub-Saharan Africa: a systematic review and meta-analysis. AIDS. 2000;14:2361-2370.
2. Bailey RC, Plummer FA, Moses S. Male circumcision and HIV prevention: current knowledge and future research directions. Lancet Infect Dis. 2001;1:223-231.
3. Siegfried N, Muller M, Deeks J, et al. HIV and male circumcision - a systematic review with assessment of the quality of studies. Lancet Infect Dis. 2005;5:165-173.
4. Agot KE, Ndinya-Achola JO, Kreiss JK, et al. Risk of HIV-1 in rural Kenya: a comparison of circumcised and uncircumcised men. Epidemiology. 2004;15:157-163.
5. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for seroconversion in men. Lancet. 1989;2:403-407.
6. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Med. 2005;2:e298 (Epub 2005 Oct 25).
7. Mills E, Menard J, Devereaux PJ, et al. Trial of circumcision for HIV prevention should be interpreted with caution. E-Letter responding to article: Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: The ANRS 1265 Trial. PLoS Med. 2005;2:e298.
8. Crepaz N, Hart TA, Marks G. Highly active antiretroviral therapy and sexual risk behavior: a meta-analytic review. JAMA. 2004;292:224-236.
9. Tun W, Gange SJ, Vlahov D, et al. Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clin Infect Dis. 2004;38:1167-1174.
10. Donoghoe MC, Stimson GV, Dolan K, et al. Changes in HIV risk behaviour in clients of syringe-exchange schemes in England and Scotland. AIDS. 1989;3:267-272.
11. Chesney MA, Chambers DB, Kahn JO. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:266-271.
12. Mattson CL, Bailey RC, Muga R, et al. Acceptability of male circumcision and predictors of circumcision preference among men and women in Nyanza Province, Kenya. AIDS Care. 2005;17:182-194.
13. Bailey RC, Muga R, Poulussen R, et al. The acceptability of male circumcision to reduce HIV infections in Nyanza Province, Kenya. AIDS Care. 2002;14:27-40.
14. Quigley MA, Weiss HA, Hayes RJ. Male circumcision as a measure to control HIV infection and other sexually transmitted diseases. Curr Opin Infect Dis. 2001;14:71-75.
15. Halperin DT, Fritz K, McFarland W, et al. Acceptability of adult male circumcision for sexually transmitted disease and HIV prevention in Zimbabwe. Sex Transm Dis. 2005;2:238-239.